It’s hard to see the text on my smartphone,” “My eyes get tired when I read books or newspapers,” or “Small text looks blurry ...
The FDA approved phentolamine ophthalmic solution 0.75% (Ryzumvi; Viatris) for the treatment of presbyopia in adults, giving ...
Azalea Vision has enrolled the first patient in its Novel Optical Aperture (NOA) proof-of-concept study for its smart contact ...
YouTube Short Video (Summary Version): Hello! I am Dr. Kaeru, a practicing physician. 🩺🐸In this video, I will provide a ...
Viatris (NasdaqGS: VTRS) received U.S. FDA approval for RYZUMVI to treat presbyopia in adults in026. RYZUMVI was previously ...
Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...
Eye drops promise clearer vision for a treatment approved following clinical trials demonstrating improvements in near vision ...
MedPage Today on MSN
FDA expands Ryzumvi approval to include presbyopia
Phentolamine eye drops significantly improved near vision after 12 weeks of treatment ...
The medication is currently approved to treat pharmacologically induced mydriasis, or pupil dilation, in adults and children ...
Aging eyes may struggle to read the dinner menu, but a prescription eye drop promises to make reading glasses optional by ...
U.S. consumers ranked multifocal contact lenses among their preferred anti-aging solutions, highlighting untapped ...
PITTSBURGH, Oct. 16, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results